Monday, 3 April 2017
Were NHS chiefs right to deny pancreatic cancer drug?
Were NHS chiefs right to deny pancreatic cancer drug? The news in late 2015 that abraxane was being rejected by NICE on cost grounds was met with anger by patient groups as some people had survived years when they had been given months to live. The Daily Mail
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment